THE ANTIMYCOBACTERIAL ACTIVITY OF B 663.

Suppr

超能文献

作者信息

BARRY V C, CONALTY M L

出版信息

Lepr Rev. 1965 Jan;36:3-7. doi: 10.5935/0305-7518.19650002.

DOI:10.5935/0305-7518.19650002

PMID:14241918

Abstract

摘要

相似文献

THE ANTIMYCOBACTERIAL ACTIVITY OF B 663.

Lepr Rev. 1965 Jan;36:3-7. doi: 10.5935/0305-7518.19650002.

'B 663' POSSIBLE ANTI-INFLAMMATORY ACTION IN LEPROMATOUS LEPROSY.

Lepr Rev. 1965 Jan;36:9-11. doi: 10.5935/0305-7518.19650003.

Experimental chemotherapy of mycobacterioses provoked by atypical mycobacteria.

Bibl Tuberc. 1970;26:154-88.

THE ANTITUBERCULOSIS ISONIAZID CHEMOPROPHYLAXIS ON HUMANS AND CATTLE.

Ann Ist Carlo Forlanini. 1963;23:SUPPL:227-423.

TREATMENT OF LEPROSY WITH B 663 APPRAISAL OF THE PILOT TRIAL AFTER THREE YEARS.

Lepr Rev. 1965 Jan;36:13-5. doi: 10.5935/0305-7518.19650004.

[ACTION OF IONIZING RADIATIONS ON MYCOBACTERIA].

Nuovi Ann Ig Microbiol. 1964 Jan-Feb;15:56-68.

RED AND BLACK PIGMENTATION DEVELOPING DURING TREATMENT OF LEPROSY WITH 'B 663'.

Lepr Rev. 1965 Jan;36:17-20. doi: 10.5935/0305-7518.19650005.

[ANTIMYCOBACTERIAL ACTIVITY OF ISOXYL. II. EXPERIMENTS WITH GUINEA PIGS AND RABBITS].

Pathol Microbiol (Basel). 1964;27:79-87.

Antimycobacterial activities of riminophenazines.

J Antimicrob Chemother. 1999 May;43(5):615-23. doi: 10.1093/jac/43.5.615.

ACTIVITY OF ANTITUBERCULOSIS DRUGS AGAINST MYCOBACTERIUM LEPRAE.

Int J Lepr. 1964 Jul-Sep;32:260-71.

引用本文的文献

Pulmonary Infections: Therapeutic Obstacles and Progress in Drug Development.

Pharmaceuticals (Basel). 2025 Jun 13;18(6):891. doi: 10.3390/ph18060891.

Clofazimine for the treatment of tuberculosis.

Front Pharmacol. 2023 Feb 2;14:1100488. doi: 10.3389/fphar.2023.1100488. eCollection 2023.

Clofazimine Inhalation Suspension Demonstrates Promising Toxicokinetics in Canines for Treating Pulmonary Nontuberculous Mycobacteria Infection.

Antimicrob Agents Chemother. 2023 Feb 16;67(2):e0114422. doi: 10.1128/aac.01144-22. Epub 2023 Jan 17.

Characterization of Clofazimine Metabolism in Human Liver Microsomal Incubation .

Antimicrob Agents Chemother. 2022 Oct 18;66(10):e0056522. doi: 10.1128/aac.00565-22. Epub 2022 Oct 3.

Investigation of Clofazimine Resistance and Genetic Mutations in Drug-Resistant Isolates.

J Clin Med. 2022 Mar 30;11(7):1927. doi: 10.3390/jcm11071927.

Activity of Riminophenazines against Mycobacterium tuberculosis: A Review of Studies that Might be Contenders for Use as Antituberculosis Agents.

ChemMedChem. 2020 Dec 3;15(23):2207-2219. doi: 10.1002/cmdc.202000580. Epub 2020 Oct 15.

Clofazimine pharmacokinetics in patients with TB: dosing implications.

J Antimicrob Chemother. 2020 Nov 1;75(11):3269-3277. doi: 10.1093/jac/dkaa310.

Clofazimine Reduces the Survival of in Macrophages and Mice.

ACS Infect Dis. 2020 May 8;6(5):1238-1249. doi: 10.1021/acsinfecdis.0c00023. Epub 2020 Apr 29.

Inhibition of the aryl hydrocarbon receptor/polyamine biosynthesis axis suppresses multiple myeloma.

J Clin Invest. 2018 Oct 1;128(10):4682-4696. doi: 10.1172/JCI70712. Epub 2018 Sep 10.

Clofazimine Inhibits the Growth of Babesia and Theileria Parasites In Vitro and In Vivo.

Antimicrob Agents Chemother. 2016 Apr 22;60(5):2739-46. doi: 10.1128/AAC.01614-15. Print 2016 May.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验